In addition to genetics and androgens, novel factors could play a role in androgenetic alopecia (AGA). This study aims to investigate the association between plasma leptin level with the risk and severity of AGA in men. Forty-eight subjects were enrolled including 29 AGA and 19 non-AGA subjects. The plasma leptin level was significantly higher in AGA subjects, compared to non-AGA subjects (4.45 vs 2.76 ng/mL,
| BACKGROUND
Androgenetic alopecia (AGA) is regarded as an androgen-mediated process that occurs in genetically susceptible patients. However, factors other than androgens are believed to be involved in the pathogenesis of AGA because anti-androgen treatment does not completely reverse miniaturization. [1] Our previous study in men with AGA revealed that obesity is associated with a higher severity of hair loss. [2] Those findings suggested that obesity-associated metabolic changes could be a modulator for the progression of AGA. Leptin is a major adipocyte-derived factor, and its plasma level is commonly up-regulated in obese subjects due to the increased adipose tissue and the concomitant development of central leptin resistance. [3] Leptin has been reported to modulate the growth of hair follicles. [4, 5] 
| QUESTIONS ADDRESSED
We hypothesize that systemic leptin levels might modulate the growth of hair follicles and subsequently impact the development and severity of hair diseases. Therefore, we conducted the current study to investigate the association between plasma leptin levels with the risk and severity of AGA in men.
| EXPERIMENTAL DESIGN
Male subjects who were diagnosed as male pattern AGA or healthy volunteers with no history of AGA (non-AGA) at the age of 20-50 years were included in this study. The details of exclusion criteria and assessment of AGA are summarized in Data S1. The blood samples were taken from all subjects in the early morning after 8 hours of fasting.
Enzyme-linked immunoassay kits were then used for the quantification of plasma levels of leptin, adiponectin, testosterone, insulin-like growth factor-1 (IGF-1) and transforming growth factor-β1 (TGF-β1).
| RESULTS
A total of 48 subjects were enrolled in this study including 29 subjects with AGA and 19 non-AGA control subjects. The mean age of AGA subjects was 28.8 years and non-AGA subjects 34.1 years. Among the AGA subjects, 17 of them were diagnosed as mild severity (grade 2-3) and 12 subjects advanced severity (grade 4-6).
BMI was not significantly different between AGA and non-AGA subjects ( Figure 1A ) and was not correlated with the onset of AGA Abbreviations: AGA, androgenetic alopecia; BMI, body mass index; IGF, insulin growth factor;
OR, odds ratio; TGF, transforming growth factor.
F I G U R E 1 BMI and plasma leptin level in AGA group (AGA+) vs non-AGA group (AGA-) and mild AGA group vs severe AGA group. The subjects were also stratified into two age groups (20-30 y and >30 y) for the analysis of plasma leptin levels. (*P<.05, **P<.01) after controlling the age of subjects (Table 1) . However, BMI was significantly higher in subjects with advanced AGA, compared to subjects with mild AGA (27.6 vs 23.1 kg/m 2 , P<.005) ( Figure 1A ). By multivariate logistic analysis, advanced AGA was also associated with a higher BMI (odds ratio [OR]=1.35, P<.05) ( Table 1 ).
The plasma level of leptin was significantly higher in AGA subjects compared to non-AGA subjects (4.4 vs 2.8 ng/mL, P<.05) ( Figure 1B ).
To prevent age as a confounding factor, we stratified the subjects into two groups according to their ages, 20-30 and >30 years. In both age groups, the same trend was observed, and AGA subjects had significantly higher plasma leptin levels than non-AGA subjects ( Figure 1B) .
Furthermore, the multivariate analysis showed that plasma leptin levels positively correlated with the risk of developing AGA after controlling for age and BMI of the subjects (OR=2.77, P<.05) ( Table 1) . Plasma level of TGF-β1 was also higher in AGA vs non-AGA subjects (Table   S1 , Table S2 ).
Plasma leptin level was significantly higher in subjects with advanced AGA compared to subjects with mild AGA (5.9 vs 3.4 ng/mL, P<.05) ( Figure 1C ). Although advanced AGA subjects tended to have higher plasma leptin levels than mild AGA subjects after stratifying the subjects according to the age, the difference did not reach the statistical significance ( Figure 1C) . Similarly, the multivariate analysis did not exhibit a significant difference (Table 1) .
| CONCLUSIONS
Our results indicated that higher plasma leptin level is associated with higher risk of developing AGA in men, independent of the effects from age and obesity. Although AGA has been regarded as an androgen-mediated disease, our study suggested leptin derived from systemic circulation is a modifying factor in the pathogenesis of AGA.
It is known that excess of plasma leptin has a negative impact on
Leydig cells function and decreased the plasma testosterone level. [6] However, it is unclear whether plasma leptin level affects the production of testosterone or dihydrotestosterone in the local environment of hair follicles, which has more implication in the development of AGA than systemic androgens. [7] The interaction between dermal adipose tissue and hair follicles is receiving more attention currently. [8] [9] [10] [11] [12] It is known that dermal adipose-derived factors, including leptin, regulate hair cycle propagation and the growth of hair follicles. [4, 5, 13] However, the impact of leptin on human hair follicles remains unclear.
TGF-β1 mediates androgen-dependent hair changes. [14, 15] Our data showing higher plasma levels of TGF-β1 in AGA vs non-AGA subjects suggest not only a localized effect from dermal papilla activity, but also a systemic effect from circulating factor implicated in the pathogenesis of AGA. The limitation in this study was the relative small number of subjects which made the power of group stratification and regression analysis less effective.
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